BMC Cancer (2023) TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer Célie Cokelaere Rüveyda Dok Veerle Janssens Cellular Oncology (2023) NFκB (RelA) mediates transactivation of hnRNPD in oral cancer cells Vikas Kumar Anurag Kumar Shyam Singh...
This work was also supported by the Austrian Science Fund (FWF) W1241 to P.W., the Austrian Science Fund (FWF) DOC 59–833 “International PhD Program in Translational Oncology – IPPTO” to R.E. and L.K., the Austrian Science Fund (FWF) P35069-B “CDHR5 in Intestinal Barrier ...
4b), suggesting Tpst2 inhibition combined with anti-PD1 as a novel therapeutic strategy in oncology. Further analysis showed a significant reduction in tumor weight with Tpst2 knock-down and a trend towards decreased tumor weight with the combination treatment (Fig. 4c). These effects were ...
Oncology Research2024,32(7), 1141-1162.https://doi.org/10.32604/or.2024.050350 Received02 February 2024;Accepted09 April 2024;Issue published20 June 2024 Abstract Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm with intermediate malignancy characterized by a propensity for recurrence but a...
Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Sites Art and Images in Psychiatry Best of the JAMA Network Caring for the Critically Ill Patient Clinical Crosswords from JAMA Coronavirus ...
Nature Communications (2023) Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease Matthew N. Mills Whitney King Kamran A. Ahmed Journal of Neuro-Oncology (2022) Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the...
2023, Cancer Cell Show abstract Scalable and efficient DNA sequencing analysis on different compute infrastructures aiding variant discovery 2024, NAR Genomics and Bioinformatics Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment 2023, Medical Oncology Advances in ...
Given the paucity of randomized clinical trials by pharmaceutical companies in pediatric oncology, the majority of agents used in this study were considered off‑label, as is the case in most standard-of-care pediatric cancer treatment regimens. One factor leading to the variability in days from...
2023. https://doi.org/10.3390/biomedicines11041071. Article PubMed PubMed Central Google Scholar Yu Y, Chang Z, Han C, et al. Long non-coding RNA MINCR aggravates colon cancer via regulating miR-708-5p-mediated Wnt/beta-catenin pathway. Biomed Pharmacother. 2020;129: 110292. https://...